Manchester United Secure Carlos Baleba in £65m Midfield Deal

Manchester United have reached an agreement to sign Carlos Baleba from Brighton in a deal valued at an initial £65 million, making him the club’s most expensive signing of the summer transfer window.

The 22-year-old midfielder is set to undergo a medical in Manchester this weekend before the transfer is officially completed. Baleba, who primarily operates as a defensive midfielder, will join Michael Carrick’s squad as the third midfield addition this summer, following the arrivals of Youri Tielemans and Andrey Santos.

Baleba’s arrival signals a continued effort by Manchester United to strengthen their midfield options ahead of the 2026-27 Premier League campaign. The club has targeted a midfield rebuild to add depth, versatility, and quality, with Baleba expected to provide a strong defensive presence in the centre of the park.

• Carlos Baleba: Defensive midfielder from Brighton, 22 years old
• Transfer fee: Initial £65 million
• Other midfield signings: Youri Tielemans (No 8), Andrey Santos (holding midfielder)
• Manager: Michael Carrick

Baleba’s signing reflects Manchester United’s ambition to compete at the highest level by reinforcing key areas of the squad. His profile as a No 6 midfielder complements Tielemans’ more advanced role and Santos’ defensive capabilities, offering Carrick a range of options in midfield dynamics and tactics.

The club’s investment in Baleba also highlights their strategy in the transfer market this summer, focusing on young, talented players who can develop and contribute immediately. With the medical scheduled for the weekend, United fans can expect an official announcement soon.

Looking ahead, Manchester United will likely integrate Baleba into their squad as they prepare for upcoming Premier League fixtures and other competitions. The addition of Baleba alongside Tielemans and Santos aims to boost the team’s midfield resilience and creativity, key factors for success in a demanding season.

For more details, visit The Guardian.